KR960705038A
(ko)
|
1993-09-03 |
1996-10-09 |
스테시 엘. 채닝 |
자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease)
|
WO1995007096A1
(en)
*
|
1993-09-06 |
1995-03-16 |
La Trobe University |
Treatment of autoimmune disease
|
US6251396B1
(en)
|
1994-11-18 |
2001-06-26 |
Neurocrine Biosciences, Inc. |
Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
|
AU5671196A
(en)
*
|
1996-03-28 |
1997-10-17 |
Immulogic Pharmaceutical Corporation |
Myelin oligodendrocyte glycoprotein peptides and uses thereof
|
SE9703287D0
(sv)
|
1997-09-11 |
1997-09-11 |
Astra Ab |
Peptides
|
PT1621208E
(pt)
|
1999-03-12 |
2010-04-07 |
Univ Leland Stanford Junior |
Vacinação com adn para tratamento de doença auto-imune
|
IL132611A0
(en)
|
1999-10-27 |
2001-03-19 |
Yeda Res & Dev |
Synthetic genes and polypeptides and pharmaceutical compositions comprising them
|
DK1267909T3
(da)
|
2000-03-29 |
2010-11-08 |
Univ Ohio State Res Found |
Fremgangsmåder til blokering af vævsdestruktion ved autoreaktive T-celler
|
CN102764425B
(zh)
|
2000-08-21 |
2015-11-25 |
阿皮托普技术(布里斯托尔)有限公司 |
肽选择方法
|
US8231878B2
(en)
|
2001-03-20 |
2012-07-31 |
Cosmo Research & Development S.P.A. |
Receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
|
IL161121A0
(en)
|
2001-10-03 |
2004-08-31 |
Harvard College |
Copolymers for suppression of autoimmune diseases, and methods of use
|
CA2614171C
(en)
|
2001-10-03 |
2012-04-24 |
President And Fellows Of Harvard College |
Copolymers for suppression of autoimmune diseases, and methods of use
|
IL146016A0
(en)
|
2001-10-17 |
2002-07-25 |
Yeda Res & Dev |
Synthetic peptides and dna sequences and compositions comprising them for treatment of multiple sclerosis
|
DK1456380T3
(da)
|
2001-11-02 |
2012-07-30 |
Giuliani Int Ltd |
SMAD7-inhibitorer til behandling af CNS-sygdomme
|
WO2004015070A2
(en)
|
2002-08-08 |
2004-02-19 |
Baylor College Of Medicine |
Isolation and identification of t cells
|
US20070042945A1
(en)
|
2002-09-25 |
2007-02-22 |
Genentech, Inc. |
Nouvelles compositions et methods de traitement du psoriasis
|
EP2316844A3
(en)
|
2003-05-21 |
2011-07-20 |
Biotech Tools S.A. |
Peptide complex
|
AU2011202900B2
(en)
|
2003-09-05 |
2012-08-02 |
Oregon Health & Science University |
Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells
|
WO2005044982A2
(en)
|
2003-09-05 |
2005-05-19 |
Oregon Health & Science University |
Monomeric recombinant mhc molecules useful for manipulation of antigen-specific t cells
|
US20090191173A1
(en)
|
2004-11-29 |
2009-07-30 |
Michal Eisenbach-Schwartz |
Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1
|
AU2012201067A1
(en)
|
2005-03-14 |
2012-03-15 |
B.G. Negev Technologies And Applications Ltd. |
Compositions of HSP60 peptides and viral antigens for vaccination and diagnosis
|
IL185932A
(en)
|
2005-03-14 |
2014-02-27 |
Yeda Res & Dev |
Viral antigens, conjugates and preparations containing them, for vaccination and diagnosis
|
CA2601518A1
(en)
|
2005-03-14 |
2006-09-21 |
Irun R. Cohen |
Compositions of hsp60 peptides and viral antigens for vaccination and diagnosis
|
US8202835B2
(en)
|
2005-06-17 |
2012-06-19 |
Yitzchak Hillman |
Disease treatment via antimicrobial peptides or their inhibitors
|
AU2006298767B2
(en)
|
2005-09-28 |
2013-01-10 |
Cytos Biotechnology Ag |
Interleukin-1 conjugates and uses thereof
|
JP5398987B2
(ja)
|
2005-11-14 |
2014-01-29 |
セルミド リミテッド |
調節性t細胞の機能異常に基づく疾患の治療方法及び予防方法
|
US7803364B2
(en)
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
ATE517178T1
(de)
|
2005-11-17 |
2011-08-15 |
Cleveland Clinic Foundation |
Multipotente neurale stammzellen
|
WO2007094003A2
(en)
|
2006-02-15 |
2007-08-23 |
Ramot At Tel Aviv University Ltd. |
Viral display vehicles for treating multiple sclerosis
|
EP1987066B1
(en)
|
2006-02-22 |
2010-12-29 |
University of Zürich |
Methods for treating demyelinating diseases
|
PL2016414T3
(pl)
|
2006-05-05 |
2016-01-29 |
Opexa Therapeutics |
Szczepionka z komórek T
|
AU2012202713B2
(en)
|
2006-05-31 |
2015-04-09 |
Lpath, Inc. |
Immune-derived moieties reactive against lysophosphatidic acid
|
AU2012202776A1
(en)
|
2006-05-31 |
2012-05-31 |
Lpath, Inc. |
Novel Bioactive Lipid Derivatives, Immune-derived Moieties Reactive Thereto, and Methods of Making and Using Same
|
US8148084B2
(en)
|
2006-06-22 |
2012-04-03 |
Dana-Farber Cancer Institute, Inc. |
Diagnosis of autoimmune disease
|
EP3170401B1
(en)
|
2006-10-25 |
2019-06-05 |
Revalesio Corporation |
Ionic aqueous fluid composition containing oxygen microbubbles
|
RU2460541C2
(ru)
|
2006-10-27 |
2012-09-10 |
Лпат, Инк. |
Композиции и способы связывания сфингозин-1-фосфата
|
US8188218B2
(en)
|
2006-10-27 |
2012-05-29 |
University Of Kansas |
Bi-functional peptides for multiple sclerosis treatment and diagnosis
|
EP2164508B1
(en)
|
2007-06-04 |
2014-01-08 |
Rappaport Family Institute for Research in the Medical Sciences |
Agents for the treatment of inflammatory diseases and methods of using same
|
EP2050814A1
(en)
|
2007-10-17 |
2009-04-22 |
Txcell |
Compositions for treating multiple sclerosis
|
US20090227018A1
(en)
|
2007-10-25 |
2009-09-10 |
Revalesio Corporation |
Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
|
WO2009056833A2
(en)
|
2007-10-31 |
2009-05-07 |
Apitope Technology (Bristol) Limited |
Composition
|
EP2245059B1
(en)
|
2008-02-14 |
2017-09-20 |
Life Sciences Research Partners VZW |
Cd4+ t-cells with cytolytic properties
|
EP2355660A4
(en)
|
2008-10-13 |
2012-05-02 |
Biovista Inc |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
|
EP2350263A4
(en)
|
2008-10-22 |
2013-07-03 |
Revalesio Corp |
COMPOSITIONS AND METHODS OF TREATING TSLP-MEDIATED ILLNESSES
|
US8871202B2
(en)
|
2008-10-24 |
2014-10-28 |
Lpath, Inc. |
Prevention and treatment of pain using antibodies to sphingosine-1-phosphate
|
US9267945B2
(en)
|
2008-11-12 |
2016-02-23 |
Yeda Research And Development Co. Ltd. |
Diagnosis of multiple sclerosis
|
EP2233502A1
(en)
|
2009-03-27 |
2010-09-29 |
Deutsches Rheuma-Forschungszentrum Berlin |
Sialylated antigen-specific antibodies for treatment or prophylaxis of unwanted inflammatory immune reactions and methods of producing them
|
BRPI1013992A2
(pt)
|
2009-04-27 |
2016-08-16 |
Revalesio Corp |
composições e métodos para o tratamento de resistência à insulina e diabetes melito
|
US8703711B2
(en)
|
2009-06-09 |
2014-04-22 |
Val-Chum, Limited Partnership |
Ninjurin-1 modulation and uses thereof
|
US8293468B2
(en)
|
2009-06-10 |
2012-10-23 |
Centre Hospitalier De L'université De Montréal |
MCAM modulation and uses thereof
|
AU2010286361A1
(en)
|
2009-08-31 |
2012-03-15 |
Amplimmune, Inc. |
Methods and compositions for the inhibition of transplant rejection
|
US9334323B2
(en)
|
2009-12-09 |
2016-05-10 |
Mitsubishi Tanabe Pharma Corporation |
Method of reducing recurrence of multiple sclerosis symptoms in a mammal by administering an anti-repulsive guidance molecule neutralizing antibody
|
WO2011097527A2
(en)
|
2010-02-04 |
2011-08-11 |
Xencor, Inc. |
Immunoprotection of therapeutic moieties using enhanced fc regions
|
US20110189178A1
(en)
|
2010-02-04 |
2011-08-04 |
Xencor, Inc. |
Immunoprotection of Therapeutic Moieties Using Enhanced Fc Regions
|
PL217128B1
(pl)
|
2010-08-02 |
2014-06-30 |
Inst Biochemii I Biofizyki Polskiej Akademii Nauk |
Syntetyczne geny kodujące fragmenty peptydowe naturalnych białek mielinowych przeznaczone do wywoływania efektu tolerancji pokarmowej, fragmenty DNA zawierające te geny, sposób otrzymywania tych peptydów w układzie mikrobiologicznym (bakteryjnym) oraz ich zastosowanie medyczne
|
US10131875B2
(en)
|
2010-08-04 |
2018-11-20 |
Duke University |
Regulatory B cells and their uses
|
EP2600885A2
(en)
|
2010-08-04 |
2013-06-12 |
Ramot at Tel Aviv University, Ltd. |
Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
|
BR112013003110A2
(pt)
|
2010-08-12 |
2016-06-28 |
Revalesio Corp |
composições e métodos para tratamento de taupatia
|
JP6027969B2
(ja)
|
2010-09-03 |
2016-11-16 |
オレゴン ヘルス アンド サイエンス ユニバーシティ |
共有結合性ペプチドを有する組み換え型t細胞受容体リガンド
|
EP2617435A4
(en)
|
2010-09-16 |
2014-03-12 |
Univ Osaka |
THERAPEUTICS AND PROPHYLACTIC AGENTS FOR COMPOSITIONS OF AUTOIMMUNE DISEASES, INFLAMMATORY DISEASES, ALLERGIC DISEASES AND ORGAN TRANSPLANTS
|
US20120076808A1
(en)
|
2010-09-27 |
2012-03-29 |
China Agricultural University |
Combined antigen and dna vaccine for preventing and treating autoimmune diseases
|
WO2012045324A1
(en)
|
2010-10-07 |
2012-04-12 |
Mediagnost Gesellschaft Fur Forschung Und Herstellung Von Diagnostika Gmbh |
Method for detecting a parkinson's disease and test system
|
CA2816225A1
(en)
|
2010-10-26 |
2012-05-03 |
Technion Research & Development Foundation Ltd. |
Antibodies which bind soluble t-cell receptor ligands
|
AU2011352036A1
(en)
|
2010-12-31 |
2013-07-18 |
Anthrogenesis Corporation |
Enhancement of placental stem cell potency using modulatory RNA molecules
|
US20130309229A1
(en)
|
2011-01-28 |
2013-11-21 |
The United States Government As Represented By The Department Of Veterans Affairs |
Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
|
US8685404B2
(en)
*
|
2011-01-31 |
2014-04-01 |
Oregon Health & Science University |
Recombinant T-cell receptor ligand for the treatment of cognitive and neuropsychiatric impairment induced by substance addiction
|
DK2560631T3
(da)
|
2011-03-01 |
2014-02-10 |
Pharnext |
Baclofen- og acamprosat-baseret af neurologiske forstyrrelser
|
JP5878447B2
(ja)
|
2012-09-12 |
2016-03-08 |
富士フイルム株式会社 |
ベースメイク化粧料
|
GB201300684D0
(en)
|
2013-01-15 |
2013-02-27 |
Apitope Int Nv |
Peptide
|